BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $204 from $255 and keeps a Buy rating on the shares. Sentiment ...

ICON Public Limited Company’s ICLR share price has surged by 5.63%, which has investors questioning if this is right time to sell.

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through ...

Let’s take a look at how Illumina (NASDAQ:ILMN) and the rest of the life sciences tools & services stocks fared in Q4. The life sciences tools and services sector supports the research ...